Table 3.
NIH No. | Phase | Indication | Promoter | Therapeutic |
9910-345 | I/II | HR metastatic | Rat probasin and PSA/PSE | Replication (E1A and E1B) |
0101-451 | II | HR metastatic | Rat probasin and PSA/PSE | Replication (E1A and E1B) + docetaxel |
NIH, National Institutes of Health; HR, hormone-refractory; PSA/PSE, prostate-specific antigen promoter/enhancer. Data derived from http://www.gemcris.od.nih.gov.